Biocon Sells 1.88% in Syngene
Bengaluru-based biotech firm, Biocon, has sold 1.88% stake in its research arm, Syngene International, for around Rs. 230-crore. According to a filing in the exchanges, Biocon sold 37,65,574 equity shares amounting to 1.88% of the equity share capital of Syngene through open market sale. Post the transaction, promoter and promoter group stakes in the company was 72.57%. Also, in a separate filing to the exchanges, Syngene said Biocon has sold the shares to achieve minimum public shareholding requirement. Public shareholding was 25.90%.
2026-07-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Saudi Aramco Completes Acquisition of 40% Stake in Gas & Oil Pakistan
-
Biocon gets eight observations for two new units in Bengaluru
-
Commercialisation plans for insulin glargine unchanged: Biocon
-
Biocon's Malaysia manufacturing facility receives EU GMP nod
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Evonik Completes Shift to Green Electricity for Polybutadiene Production at its Marl, Germany, Plant
-
Narrowing of the Average Difference! Acrylic Acid Decline Slows, Market Fluctuates and Stagnates
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
Recommend Reading
-
Brazil’s SISPA Platform Signals a New Phase in Pesticide Registration
-
Record Net Profit, Yet “Joining Forces” with a Rival? Axalta Drops a Final Trump Card Before the Merger
-
Mitsubishi Gas Chemical Halts MXDA Plant Construction in the Netherlands Amid Rising Costs and Market Pressures
-
BASF, Sinopec Forge Green Alliance to Power Nanjing Site with Certified Bio-Methane
-
Univar Solutions Expands EMEA Portfolio Through Exclusive Distribution Agreement with CABB Group
-
Multiple Positive Factors Support Butadiene Prices Rising Over 29% in January
-
2025 Epoxy Chloropropane Market Review and 2026 Outlook in China
-
January Activated Carbon Prices Fluctuate and Rise in China
-
Insufficient Downstream Demand, DMF Market Primarily Remains Stable
-
Business Society: Bisphenol A Market to Stabilize First, Then Strengthen in January 2026